Westlake Chemical Corporation (WLK) - Net Assets
Based on the latest financial reports, Westlake Chemical Corporation (WLK) has net assets worth $9.94 Billion USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($19.81 Billion) and total liabilities ($9.88 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Westlake Chemical Corporation liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.94 Billion |
| % of Total Assets | 50.16% |
| Annual Growth Rate | 15.65% |
| 5-Year Change | 67.88% |
| 10-Year Change | 210.03% |
| Growth Volatility | 15.4 |
Westlake Chemical Corporation - Net Assets Trend (2002–2024)
This chart illustrates how Westlake Chemical Corporation's net assets have evolved over time, based on quarterly financial data. Also explore WLK total asset value for the complete picture of this company's asset base.
Annual Net Assets for Westlake Chemical Corporation (2002–2024)
The table below shows the annual net assets of Westlake Chemical Corporation from 2002 to 2024. For live valuation and market cap data, see WLK stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $11.04 Billion | +2.59% |
| 2023-12-31 | $10.76 Billion | +2.86% |
| 2022-12-31 | $10.46 Billion | +22.71% |
| 2021-12-31 | $8.53 Billion | +29.64% |
| 2020-12-31 | $6.58 Billion | +2.73% |
| 2019-12-31 | $6.40 Billion | +5.38% |
| 2018-12-31 | $6.08 Billion | +13.17% |
| 2017-12-31 | $5.37 Billion | +37.95% |
| 2016-12-31 | $3.89 Billion | +9.27% |
| 2015-12-31 | $3.56 Billion | +11.24% |
| 2014-12-31 | $3.20 Billion | +32.39% |
| 2013-12-31 | $2.42 Billion | +29.18% |
| 2012-12-31 | $1.87 Billion | +6.60% |
| 2011-12-31 | $1.76 Billion | +16.69% |
| 2010-12-31 | $1.51 Billion | +17.13% |
| 2009-12-31 | $1.28 Billion | +3.71% |
| 2008-12-31 | $1.24 Billion | -3.70% |
| 2007-12-31 | $1.29 Billion | +9.64% |
| 2006-12-31 | $1.17 Billion | +18.05% |
| 2005-12-31 | $994.11 Million | +29.21% |
| 2004-12-31 | $769.40 Million | +64.51% |
| 2003-12-31 | $467.70 Million | +3.79% |
| 2002-12-31 | $450.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Westlake Chemical Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1048100000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $10.48 Billion | 99.56% |
| Common Stock | $1.00 Million | 0.01% |
| Other Comprehensive Income | $-144.00 Million | -1.37% |
| Other Components | $189.00 Million | 1.80% |
| Total Equity | $10.53 Billion | 100.00% |
Westlake Chemical Corporation Competitors by Market Cap
The table below lists competitors of Westlake Chemical Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bureau Veritas SA
PA:BVI
|
$12.07 Billion |
|
BUREAU VERITAS ADR EO-12
F:4BV0
|
$12.07 Billion |
|
GlobalWafers Co Ltd
TWO:6488
|
$12.08 Billion |
|
Align Technology Inc
NASDAQ:ALGN
|
$12.09 Billion |
|
AGNC Investment Corp
NASDAQ:AGNC
|
$12.03 Billion |
|
MAPFRE S.A.ADR 2 / EO-10
F:CMA
|
$12.03 Billion |
|
Topbuild Corp
NYSE:BLD
|
$12.02 Billion |
|
Fresenius Medical Care AG & Co. KGaA
XETRA:FME
|
$12.02 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Westlake Chemical Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 10,241,000,000 to 10,527,000,000, a change of 286,000,000 (2.8%).
- Net income of 602,000,000 contributed positively to equity growth.
- Dividend payments of 264,000,000 reduced retained earnings.
- Share repurchases of 60,000,000 reduced equity.
- Other comprehensive income decreased equity by 46,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $602.00 Million | +5.72% |
| Dividends Paid | $264.00 Million | -2.51% |
| Share Repurchases | $60.00 Million | -0.57% |
| Other Comprehensive Income | $-46.00 Million | -0.44% |
| Other Changes | $54.00 Million | +0.51% |
| Total Change | $- | 2.79% |
Book Value vs Market Value Analysis
This analysis compares Westlake Chemical Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.15x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 21.46x to 1.15x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-12-31 | $4.37 | $93.85 | x |
| 2000-12-31 | $5.09 | $93.85 | x |
| 2002-12-31 | $4.33 | $93.85 | x |
| 2003-12-31 | $4.50 | $93.85 | x |
| 2004-12-31 | $6.95 | $93.85 | x |
| 2005-12-31 | $7.62 | $93.85 | x |
| 2006-12-31 | $8.99 | $93.85 | x |
| 2007-12-31 | $9.85 | $93.85 | x |
| 2008-12-31 | $9.44 | $93.85 | x |
| 2009-12-31 | $9.73 | $93.85 | x |
| 2010-12-31 | $11.46 | $93.85 | x |
| 2011-12-31 | $13.25 | $93.85 | x |
| 2012-12-31 | $14.05 | $93.85 | x |
| 2013-12-31 | $18.08 | $93.85 | x |
| 2014-12-31 | $21.79 | $93.85 | x |
| 2015-12-31 | $24.69 | $93.85 | x |
| 2016-12-31 | $27.11 | $93.85 | x |
| 2017-12-31 | $37.63 | $93.85 | x |
| 2018-12-31 | $43.00 | $93.85 | x |
| 2019-12-31 | $45.51 | $93.85 | x |
| 2020-12-31 | $47.18 | $93.85 | x |
| 2021-12-31 | $61.81 | $93.85 | x |
| 2022-12-31 | $77.08 | $93.85 | x |
| 2023-12-31 | $79.64 | $93.85 | x |
| 2024-12-31 | $81.47 | $93.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Westlake Chemical Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.72%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.96%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 1.97x
- Recent ROE (5.72%) is below the historical average (13.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 8.73% | 3.57% | 0.79x | 3.11x | $-5.50 Million |
| 2000 | 10.91% | 3.95% | 1.01x | 2.73x | $4.58 Million |
| 2002 | -1.65% | -0.66% | 0.82x | 3.06x | $-49.91 Million |
| 2003 | 3.31% | 1.04% | 1.04x | 3.07x | $-29.80 Million |
| 2004 | 15.69% | 6.08% | 1.25x | 2.07x | $43.78 Million |
| 2005 | 22.82% | 9.29% | 1.34x | 1.84x | $127.41 Million |
| 2006 | 16.58% | 7.83% | 1.19x | 1.77x | $77.20 Million |
| 2007 | 8.92% | 3.59% | 1.24x | 2.00x | $-13.94 Million |
| 2008 | -2.38% | -0.80% | 1.61x | 1.85x | $-153.45 Million |
| 2009 | 4.12% | 2.28% | 0.95x | 1.90x | $-75.50 Million |
| 2010 | 14.71% | 6.98% | 1.07x | 1.96x | $70.89 Million |
| 2011 | 14.74% | 7.15% | 1.11x | 1.86x | $83.33 Million |
| 2012 | 20.59% | 10.80% | 1.05x | 1.82x | $198.33 Million |
| 2013 | 25.24% | 16.24% | 0.93x | 1.68x | $368.56 Million |
| 2014 | 23.30% | 15.37% | 0.85x | 1.79x | $387.37 Million |
| 2015 | 19.78% | 14.47% | 0.80x | 1.71x | $319.41 Million |
| 2016 | 11.32% | 7.86% | 0.47x | 3.09x | $46.64 Million |
| 2017 | 26.75% | 16.22% | 0.67x | 2.48x | $816.60 Million |
| 2018 | 17.82% | 11.53% | 0.74x | 2.08x | $437.00 Million |
| 2019 | 7.18% | 5.19% | 0.61x | 2.26x | $-165.00 Million |
| 2020 | 5.46% | 4.40% | 0.54x | 2.29x | $-274.30 Million |
| 2021 | 25.33% | 17.11% | 0.64x | 2.32x | $1.22 Billion |
| 2022 | 22.63% | 14.23% | 0.77x | 2.07x | $1.25 Billion |
| 2023 | 4.68% | 3.82% | 0.60x | 2.05x | $-545.10 Million |
| 2024 | 5.72% | 4.96% | 0.59x | 1.97x | $-450.70 Million |
Industry Comparison
This section compares Westlake Chemical Corporation's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $855,794,216
- Average return on equity (ROE) among peers: 6.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Westlake Chemical Corporation (WLK) | $9.94 Billion | 8.73% | 0.99x | $12.04 Billion |
| Albemarle Corp (ALB) | $1.07 Billion | 18.22% | 1.67x | $19.80 Billion |
| Alto Ingredients Inc (ALTO) | $4.47 Million | 26.15% | 0.13x | $212.84 Million |
| Aemetis Inc (AMTX) | $-216.98 Million | 0.00% | 0.00x | $154.69 Million |
| Air Products and Chemicals Inc (APD) | $2.10 Billion | 12.92% | 1.14x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $3.58 Billion | 6.50% | 2.06x | $2.52 Billion |
| Avient Corp (AVNT) | $729.10 Million | -6.32% | 1.83x | $3.16 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.21 Billion | -18.56% | 4.56x | $6.08 Billion |
| Balchem Corporation (BCPC) | $17.90 Million | 17.32% | 0.23x | $5.16 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $7.18 Million | 10.47% | 0.33x | $4.87 Million |
| Bon Natural Life Ltd (BON) | $58.00 Million | -3.44% | 0.47x | $7.30 Million |
About Westlake Chemical Corporation
Westlake Corporation manufactures and markets performance and essential materials, and housing and infrastructure products in the United States, Canada, Germany, China, Mexico, Brazil, France, Italy, and internationally. The Performance and Essential Materials segment offers ethylene, polyethylene, styrene, chlor-alkali, chlorinated derivative products, ethylene dichloride, vinyl chloride monomer… Read more